Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
16-18 November 2027
Congress Center HamburgHamburg, Germany
16-18 November 2027 |Congress Center Hamburg, Hamburg, Germany

Accelerate Therapeutics to Market. Expedite R&D. Improve CMC Efficiency.

Join the leading conference in Europe to access new data & case studies from world-renowned speakers and companies across the entire landscape of oligonucleotides, peptides, mRNA, drug delivery and partnering strategies - from discovery to market.

TIDES Europe by the Numbers

+

Attendees

+

Speakers

+

Exhibitors

3

Immersive Workshops

3

Content-Driven Tracks

Cross-Pollinate Expertise Across Oligonucleotides, Peptides, mRNA, Genome Editing and Drug Delivery

Cross-Fertilize Ideas and Best Practices with Industry Experts Across Multiple Discipline Areas:

The TIDES Europe conference agenda features scientific tracks covering in-depth discovery, development and manufacturing strategies, trends and technologies across the entire oligonucleotide and peptide spectrum and areas of focus below.

Scientist conducting molecular research, studying the structure and function of biological molecules including DNA, RNA, and proteins essential for life processes.

Oligonucleotide Chemistry, Manufacturing & Controls

Comprehensive CMC, analytical, manufacturing and regulatory strategies for both drug substance and drug product to accelerate oligonucleotide product development.

Image shows clinical trial phases in drug development process, demonstrating the sequential testing stages that ensure treatment safety and effectiveness before public release.

Oligonucleotide Discovery, Preclinical and Clinical

Design oligonucleotides with better drug-like properties to accelerate your products to the clinic and to market. The latest preclinical and clinical updates to benchmark your research and improve your clinical efforts.

The image shows a gas chromatograph, which is an analytical instrument used to separate and analyze chemical compounds in a sample.

Peptide Chemistry, Manufacturing & Controls

Improve process efficiencies and overcome challenges in process development, CMC and manufacturing. Understand regulatory expectations, new technologies and alternative approaches for emerging complex molecules.

Woman scientist reading data from a tablet while in a lab.

Peptide Discovery, Preclinical and Clinical

Explore new frontiers in peptide synthesis, discovery, design and engineering to improve targeting, delivery and drug-like properties. Case studies on the latest preclinical and clinical successes of peptides and peptide-like scaffolds and structures.

Vaccine production

mRNA Therapeutics and Genome Editing

Hear updates on discovery strategies, clinical progress and CMC approaches for mRNA therapeutics and vaccines from industry-leading companies

Two different drug delivery capsules

Macromolecular Drug Delivery

Learn about the latest technologies and approaches to overcome the delivery challenges of oligonucleotides, peptides, mRNA and other macromolecules and discover new delivery strategies for genome editing

Engage Quality Decision-Makers at TIDES Europe!

Whether you're looking to generate quality leads, showcase thought leaders, or reinforce your brand, collaborate with us to identify custom sponsorship opportunities to help you reach your business objectives.

Contact us to begin customizing your event presence today:

Companies #, A-F: Jennifer Wickett, JWickett@informaconnectls.com

Companies G-Z: Michael Moriarty, MMoriarty@informaconnectls.com

Ömer Faruk Fırat

R&D Director

Polifarma

Attending TIDES has been a valuable experience for our team.

Beyond the high scientific quality of the presentations, the conference has provided an excellent opportunity to establish new connections with technology providers and potential development partners in the oligonucleotide field. The yearly TIDES conferences are among the most important events within peptide and oligonucleotide discovery and development and it has always been among my high priority to be able to join them.

BioXconomy

BioXconomy, owned by Informa, engages the industry, builds community, and connects life sciences professionals to current, credible information, products and services relevant to their business. As the official media partner for Informa Life Sciences flagship events including: TIDES Europe, TIDES USA, BIO-Europe and LSX World Congress - BioXconomy offers our audiences exclusive event-based insights, updated news and features, and interactive media. Find out the latest developments in Modalities here.

FAQs

expand_less

What is TIDES Europe?

TIDES Europe 2026 is Europe's premier event for oligonucleotide and peptide therapeutics, bringing together over 900 attendees from across the pharmaceutical and biotech industries. The conference focuses on the latest advances in discovery, development, and manufacturing of oligonucleotide and peptide therapeutics.